Recruiting Ivonescimab in the Treatment of Multiple Advanced Tumors NCT06683846 Conditions Adenocarcinoma, Adrenal Cortical Cancer, Angiomyolipoma, +56 more Locations Fudan University Cancer Hospital — Shanghai, Shanghai Municipality, China View Trial Details
Not Yet Recruiting Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma NCT07689240 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more Locations Not specified View Trial Details
Active, Not Recruiting Comparing the Combination of Sullumab and Fruquintinib in Postoperative Adjuvant Therapy for High Recurrence Risk Non Transparent Renal Cell Carcinoma NCT07488533 Conditions Non-Clear Cell Renal Cell Carcinoma Locations Sun Yat-sen University Cancer Center — Guangzhou, Guangdong, China View Trial Details
Active, Not Recruiting Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma NCT05678673 Conditions Non-Clear Cell Renal Cell Carcinoma Locations Exelixis Clinical Site #1 — Duarte, California, United States Exelixis Clinical Site #164 — Newport Beach, California, United States Exelixis Clinical Site #162 — San Francisco, California, United States Exelixis Clinical Site #163 — Aurora, Colorado, United States View all 163 locations View more locations Show fewer locations Loading locations... View Trial Details
